Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway

Heba Alshaker(University of East Anglia), Dmitri Pchejetski(University of East Anglia), Mathias Winkler(National Health Service), Oleg Blyuss(University of Hertfordshire), Jonathan Krell(Imperial College London), Justin Stebbing(Anglia Ruskin University), Ernesto Yagüe(Imperial College London), Jonathan Waxman, Adam E. Frampton(Hammersmith Hospital), Alexey Zaikin(National Research University Higher School of Economics)
Breast Cancer Research
October 24, 2014
10.1186/s13058-014-0426-6
Cited by 73

Related Papers

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
|JAMA|2022|909
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
|The Lancet Oncology|2020|234